New Moffitt consortium study highlights the long-term benefits of CAR T-cell therapy, axicabtagene ciloleucel, for lymphoma patients. Senior author Michael Jain, MD PhD says nearly 30% achieved progression-free survival at 5 years, but challenges like infections and secondary cancers remain. Read more: https://lnkd.in/eAyCE6ag #Lymphoma #CancerResearch
Moffitt Cancer Center
Hospitals and Health Care
Tampa, FL 72,222 followers
To contribute to the prevention and cure of cancer
About us
At Moffitt Cancer Center, we come face-to-face with cancer every day, but we also see courage. And it inspires us to be the safest and best place for cancer care – to bring greater hope to every patient we serve. It’s why we’ve been continually named One of the Top Places to Work in the Tampa Bay Area. As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Moffitt is the top cancer hospital in Florida according to U.S. News & World Report and has been nationally ranked since 1999. Because working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer. Join a dedicated, diverse and inclusive team of over 7,000 to be a part of the Courageous future we envision.
- Website
-
https://moffitt.org
External link for Moffitt Cancer Center
- Industry
- Hospitals and Health Care
- Company size
- 5,001-10,000 employees
- Headquarters
- Tampa, FL
- Type
- Nonprofit
- Founded
- 1986
- Specialties
- Magnet recognition granted by the American Nurses Credentialing Center, NCI-designated Comprehensive Cancer Center, DiversityInc’s Top Hospitals & Health Systems list, Tampa Bay Times Top Workplaces, Computerworld’s 100 Best Places to Work in IT, Leader in LGBTQ Healthcare Equality, and Top cancer hospital in Florida and the Southesast according to U.S. News & World Report
Locations
Employees at Moffitt Cancer Center
Updates
-
The future is taking shape! Moffitt at SouthShore is bringing innovative care to patients in South Hillsborough starting in January 2025. Learn more: https://lnkd.in/eCZrr_CC
-
A surge in newer bispecific antibodies (BsAbs) and bispecific T-cell engagers (BiTEs), a specialized subtype of BsAbs, may be signalling a new era in cancer treatment. https://lnkd.in/ez8A9DUS
-
#FlashbackFriday to the graduation of the first cohort of the CancerX Accelerator program. So excited to see the achievements of this inaugural class and looking forward to our 2025 Cohort. If you're interested in joining the next Cohort as a startup, Champion or mentor sign up here to get the latest updates: https://lnkd.in/ebpXGwXa
🎉 CancerX is thrilled to announce the graduation of the 16 startup companies from the first cohort of our Accelerator program! Over four months, the Startups engaged in 16 curriculum sessions led by CancerX Accelerator Champions and Mentors. Topics included business scaling, government innovation, frontline healthcare, and industry partnerships, which assisted the startups in growing their businesses in various areas. By graduating from the Accelerator program, these startups now have a roadmap to successfully scale their company, an opportunity to move forward with their sponsor, and a strong community supporting their development. Because of the collaboration, support, and incredible contributions between Startups, Champions, and Mentors in the Accelerator program, the inaugural class is generating and scaling ideas that have the potential to save lives and improve the experience of cancer patients and their caregivers. The success of the CancerX Accelerator program is yet another milestone for CancerX in achieving our mission in support of Cancer Moonshot, and the potential to win the battle against cancer is within our grasp. 👏 After the incredible success of the first Cohort, we’re thrilled to offer you the chance to be involved in our next cohort! Submissions for Cohort 2025 will open soon, and if you want to join the CancerX Accelerator as a startup, Champion, or mentor, be the first to hear about the details for Cohort 2025 by signing up here: https://lnkd.in/ebpXGwXa The Blue Box Biomedical Solutions, C the Signs, Cancer Insights, Curiva, EnteroTrack LLC., Gesund.ai, Gray Oncology Solutions, Lind, Mika, Navya Care, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, XanthosHealth
-
Join Moffitt as a Cytotechnologist and discover a rewarding career. In this role, you will perform screening and interpretation of all cytopathology samples, including fine needle aspirations, exfoliative non-gynecologic, and gynecologic samples. https://lnkd.in/eFkJczTK
-
Join us for an engaging conversation with Moffitt’s world-renowned genitourinary oncology Program. Led by Department Chair Dr. Julio Pow-Sang, you’ll get an inside look at pioneering discoveries in research and the development of new clinical trials targeted at prostate cancers.
This content isn’t available here
Access this content and more in the LinkedIn app
-
From digital whiteboards to voice-controlled assistants, Moffitt McKinley Hospital is setting new standards in patient-centered care with the integration of Amazon Alexa. Read more: https://lnkd.in/ed2sCdhq
-
The recent FDA-approvals for cellular therapies for blood and solid tumors offer new hope for patients and highlight the rapid evolution and impact of cell therapies in oncology. https://lnkd.in/etHQ_3jd
-
8/5 Tropical Weather Update: Moffitt Cancer Center is open today with normal hours, including in-person and virtual visits. A flood watch is in effect for Hillsborough County until 8 tonight. Please be safe and allow yourself extra time to make it to Moffitt. Please monitor http://Moffitt.org for updates.